Evaxion A/S (NASDAQ: EVAX) announced preclinical data for EVX-04, an experimental therapeutic vaccine for acute myeloid leukemia. The Copenhagen-based biotechnology ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE